Abstract
Hartfalen (decompensatio cordis) is een klinisch syndroom dat gekenmerkt wordt door het tekortschieten van de pompwerking van het hart, leidend tot een complex van klachten en verschijnselen (tabel 1.2). Om de tekortschietende werking van het hart op te vangen treden compensatiemechanismen in werking, zoals bijvoorbeeld activatie van het renine-angiotensine-aldosteronsysteem.3 In de loop der tijd zijn veel definities voorgesteld (tabel 1.3),4 maar door het ontbreken van een gouden standaard voor het vaststellen van de aan- of afwezigheid van hartfalen heeft geen van deze definities wijde navolging gekregen. Voor het graderen van de ernst van hartfalen wordt vaak de classificatie van de New York Heart Association (NYHA-classificatie) gebruikt (tabel 1.4).
Literatuur
Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002: 3068-3072.
Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med 2002, 347: 305-313.
Jackson G, Gibbs CR, Davies MK, Lip GY. ABC of heart failure. Pathophysiology. bmj 2000, 320: 167-170.
Davis RC, Hobbs FD, Lip GY. ABC of heart failure. History and epidemiology. bmj 2000, 320: 39-42.
Nederlandse Vereniging voor Cardiologie en Nederlandse Hartstichting. Multidisciplinaire richtlijn chronisch hartfalen. Alphen aan den Rijn; Van Zuiden Communications bv; 2002.
Hunt SA, Baker DW, Chin MH, et al. acc/aha guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2001, 38: 2101-2113.
Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: acc/aha guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1999, 34: 890-911.
Vasan RS, Benjamin EJ, Levy D. Congestive heart failure with normal left ventricular systolic function. Clinical approaches to the diagnosis and treatment of diastolic heart failure. Arch Intern Med 1996, 156: 146-157.
Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologie perspective. J Am Coll Cardiol 1995, 26: 1565-1574.
Mosterd A, Hoes AW, de Bruyne MC, et al. Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J 1999, 20: 447-455.
Petrie M, McMurray J. Changes in notions about heart failure. Lancet 2001, 358: 432-434.
Gandhi SK, Powers JC, Nomeir AM, et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001, 344: 17-22.
Vasan RS, Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 2000, 101: 2118-2121.
Grossman W. Defining diastolic dysfunction. Circulation 2000, 101: 2020-2021.
Caruana L, Petrie MC, Davie AP, McMurray JJ. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from ‘diastolic heart failure’ or from misdiagnosis? A prospective descriptive study. bmj 2000, 321: 215-218.
Gaasch WH. Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction. jama 1994, 271: 1276-1280.
Zile MR, Gaasch WH, Carroll JD, et al. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation 2001, 104: 779-782.
Lip GY, Gibbs CR, Beevers DG. abc of heart failure: aetiology. bmj 2000, 320: 104-107.
McDonagh TA, Morrison CE, Lawrence A, et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997, 350: 829-833.
Redfield MM, Jacobsen SJ, Burnett jr JC, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemie, jama 2003, 289: 194-202.
Vasan RS, Larson MG, Benjamin EJ, Evans JC, Levy D. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med 1997, 336: 1350-1355.
Anonymous. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The solvd Investigators. N Engl J Med 1992, 327: 685-691.
Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (solvd). Circulation 1990, 82: 1724-1729.
Cowie MR, Mosterd A, Wood DA, et al. The epidemiology of heart failure. Eur Heart J 1997, 18: 208-225.
McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart 2000, 83: 596-602.
Mosterd A, Deckers JW, Hoes AW, et al. Classification of heart failure in population based research: an assessment of six heart failure scores. Eur J Epidemiol 1997, 13: 491-502.
Mosterd A. Heart failure in the population at large; news from the real world. Eur Heart J 1999, 20: 398-9.
Rutten FH, Grobbee DE, Hoes AW. Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail 2003, 5: 337-344.
Cost B, Grobbee DE, van der Schoot-van Venrooy J, et al. Incidence and risk factors of heart failure. Proefschrift. Rotterdam; 2000.
Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993, 88: 107-115.
Cowie MR, Wood DA, Coats AJ, et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart 2000, 83: 505-510.
Mosterd A, Cost B, Hoes AW, et al. The prognosis of heart failure in the general population. The Rotterdam Study. Eur Heart J 2001, 22: 1318-1327.
Poole-Wilson PA, Uretsky BF, Thygesen K, Cleland JG, Massie BM, Ryden L. Mode of death in heart failure: findings from the atlas trial. Heart 2003, 89: 4248.
Cowburn PJ, Cleland JG, Coats AJ, Komajda M. Risk stratification in chronic heart failure. Eur Heart J 1998, 19: 696-710.
Cowie MR. Estimating prognosis in heart failure: time for a better approach. Heart 2003, 89: 587-588.
Bouvy ML, Heerdink ER, Leufkens HG, Hoes AW. Predicting mortality in patients with heart failure: a pragmatic approach. Heart 2003, 89: 605-9.
Bonneux L, Barendregt JJ, Meeter K, Bonsel GJ, van der Maas PJ. Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure. Am J Public Health 1994, 84: 20-28.
Stewart S, MacIntyre K, Capewell S, McMurray JJ. Heart failure and the ageing population: an increasing burden in the 21st century? Heart 2003, 89: 49-53.
Stewart S, Maclntyre K, MacLeod MM, Bailey AE, Capewell S, McMurray JJ. Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemie that has reached its peak? Eur Heart J 2001, 22: 209-217.
Mosterd A, Reitsma JB, Grobbee DE. ace inhibition and hospitalisation rates for heart failure, the Netherlands 1980-1999. The end of an epidemie? Heart 2002, 87: 388-392.
Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002, 347: 1397-402.
Reitsma JB, Mosterd A, de Craen AJ, et al. Increase in hospital admission rates for heart failure in The Netherlands, 1980-1993. Heart 1996, 76: 388-392.
Michalsen A, Konig G, Thimme W. Preventable causative factors leading to hospital admission with decompensated heart failure. Heart 1998, 80: 437-441.
Cleland JG, Swedberg K, Poole-Wilson PA. Successes and failures of current treatment of heart failure. Lancet 1998, 352 Suppl 1: SI19-SI28.
McKelvie RS, Benedict CR, Yusuf S. Evidence based cardiology: prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction. bmj 1999, 318: 1400-1402.
Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. jama 1996, 275: 1557-1562.
Gottdiener JS, Arnold AM, Aurigemma GP, et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000, 35: 1628-1637.
Hoffman RM, Psaty BM, Kronmal RA. Modifiable risk factors for incident heart failure in the coronary artery surgery study. Arch Intern Med 1994; 154: 417-423.
aha. Heart and Stroke Facts: 1995 statistical supplement. Dallas, Texas: American Heart Association; 1995.
Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation 1993, 87: 755-763.
Guidry UC, Evans JC, Larson MG, Wilson PW, Murabito JM, Levy D. Temporal trends in event rates after Q-wave myocardial infarction: the Framingham Heart Study. Circulation 1999, 100: 2054-2059.
Eriksson H, Svardsudd K, Larsson B, et al. Risk factors for heart failure in the general population: the study of men born in 1913. Eur Heart J 1989. 10: 647-656.
de Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003, 24: 1601-10.
cbo. Behandeling en preventie van coronaire hartziekten door verlaging van de plasmacholeterolconcentratie. Consensus Cholesterol. Tweede herziening. Utrecht: Centraal begeleidingsorgaan voor de intercollegiale toetsing; 1998. 2003.
Rutten GEHM, Burgers JS, Heine RJ, et al. nhg standaard diabetes mellitus. Utrecht: nhg; 1999.2003.
Coumans B, Leurs MTW. Richtlijn gezond bewegen. Geneeskunde en Sport 2001, 34: 142-146.
nhg. Minimale interventie strategie. Cahier over methoden om met roken te stoppen.Utrecht: nhg; 2003.
Pearson TA, Bazzarre TL, Daniels SR, et al. American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation 2003, 107: 645-651.
Suskin N, Sheth T, Negassa A, Yusuf S. Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction. J Am Coll Cardiol 2001, 37: 1677-1682.
Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with anti-hypertensive therapies used as first-line agents. A systematic review and meta-analysis. jama 1997, 277: 739-745.
cbo. Richtlijn diagnostiek en behandeling verhoogde bloeddruk. Utrecht: Centraal buro voor de intercollegiale toetsing; 2000.2003.
Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The save Investigators. N Engl J Med 1992, 327: 669-677.
Kober L, Torp-Pedersen C, Carlsen JE, et al. A clinical trial of the angiotensinconverting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (trace) Study Group. N Engl J Med 1995, 333: 1670-1676.
Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985, 27: 335-3371.
Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the capricorn randomised trial. Lancet 2001, 357: 1385-1390.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2004 Bohn Stafleu Van Loghum, Houten
About this chapter
Cite this chapter
Mosterd, A., Hoes, A. (2004). Inleiding: definitie en epidemiologie. In: Zorg rondom hartfalen. Zorg rondom hartfalen. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-313-9399-2_1
Download citation
DOI: https://doi.org/10.1007/978-90-313-9399-2_1
Publisher Name: Bohn Stafleu van Loghum, Houten
Print ISBN: 978-90-313-3769-9
Online ISBN: 978-90-313-9399-2
eBook Packages: Dutch language eBook collection